Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis.
Dimitriou F, Staeger R, Ak M, Maissen M, Kudura K, Barysch MJ, Levesque MP, Cheng PF, Dummer R, Mangana J. Dimitriou F, et al. Among authors: kudura k. Cancers (Basel). 2021 Jun 11;13(12):2931. doi: 10.3390/cancers13122931. Cancers (Basel). 2021. PMID: 34208218 Free PMC article.
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget's disease.
Nordmann TM, Messerli-Odermatt O, Meier L, Micaletto S, Coppetti T, Nägeli M, Kamarachev J, Kudura K, Freiberger SN, Rordorf T, Mangana J, Braun R, Dummer R. Nordmann TM, et al. Among authors: kudura k. Oncotarget. 2019 Nov 19;10(62):6647-6650. doi: 10.18632/oncotarget.27272. eCollection 2019 Nov 19. Oncotarget. 2019. PMID: 31803359 Free PMC article.
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition.
Basler L, Gabryś HS, Hogan SA, Pavic M, Bogowicz M, Vuong D, Tanadini-Lang S, Förster R, Kudura K, Huellner MW, Dummer R, Guckenberger M, Levesque MP. Basler L, et al. Among authors: kudura k. Clin Cancer Res. 2020 Aug 15;26(16):4414-4425. doi: 10.1158/1078-0432.CCR-20-0020. Epub 2020 Apr 6. Clin Cancer Res. 2020. PMID: 32253232 Free article.
Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [18F]FDG PET/CT.
Liberini V, Messerli M, Husmann L, Kudura K, Grünig H, Maurer A, Skawran S, Orita E, Pizzuto DA, Deandreis D, Dummer R, Mangana J, Mihic-Probst D, Rupp N, Huellner MW. Liberini V, et al. Among authors: kudura k. Eur Radiol. 2021 Oct;31(10):8011-8020. doi: 10.1007/s00330-021-07852-7. Epub 2021 Mar 25. Eur Radiol. 2021. PMID: 33768288 Free PMC article.
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.
Hilbers ML, Dimitriou F, Lau P, Bhave P, McArthur GA, Zimmer L, Kudura K, Gérard CL, Levesque MP, Michielin O, Dummer R, Cheng PF, Mangana J. Hilbers ML, et al. Among authors: kudura k. Eur J Cancer. 2021 Oct;156:149-163. doi: 10.1016/j.ejca.2021.07.028. Epub 2021 Aug 25. Eur J Cancer. 2021. PMID: 34454317 Free article.
37 results